Myprodol^®의 코 수술 후 통증에 미치는 효과

Background and Objectives: Although various analgesics have been administrated for postoperative pain control in outpatient nasal surgery, postoperative pain has not been effectively controlled until now. Recently, Myprodol^®, a combination analgesics with codein, ibuprofen and paracetamol was developed and used as a new analgesics. This study was performed to evaluate the effectiveness of Myprodol^® for postoperative pain control in outpatient nasal surgery. Materials and Methods: We studied 40 cases of outpatient nasal surgery, which were composed of 20 cases of septoplasty and 20 cases of ethmoidectomy. We classified 2 groups which consisted of 10 cases of septoplasty and 10 cases of ethmoidectomy respectively. The tiapropenic acid 1 tablet were administrated three times per day for 2 days in the first group postoperatively. The Myprodol^® 2 capsules were administrated three times per day for 2 days in the second group postoperatively. We evaluated the postoperative pain with Verbal Rating Pain Scores (VRP), Visual Analogue Pain Scores (VAS) and satisfactory scores to pain control. Results: Overall, Myprodol^®-administrated group showed statistically significant better VRP and VAS than tiapropenic acid-administrated group. Satisfactory scores to pain control was higher in Myprodol^®-administrated group than tiapropenic acid-administrated group, too. Conclusion: We conclude that Myprodol^® is an effective oral analgesics for postoperative pain control in outpatient nasal surgery. (J Clinical Otolaryngol 1999;10:211–216)